000 01504 a2200445 4500
005 20250514035035.0
264 0 _c20020802
008 200208s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.2002.tb04306.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKürthy, Maria
245 0 0 _aEffect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic rat models.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJun 2002
300 _a482-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aDiabetic Neuropathies
_xdrug therapy
650 0 4 _aGuanidines
_xpharmacology
650 0 4 _aHydroxylamines
_xtherapeutic use
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aInsulin Resistance
650 0 4 _aMale
650 0 4 _aMetformin
_xpharmacology
650 0 4 _aPioglitazone
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aRats, Zucker
650 0 4 _aStreptozocin
650 0 4 _aThiazoles
_xpharmacology
650 0 4 _aThiazolidinediones
700 1 _aMogyorósi, Tamás
700 1 _aNagy, Károly
700 1 _aKukorelli, Tibor
700 1 _aJednákovits, Andrea
700 1 _aTálosi, László
700 1 _aBíró, Katalin
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 967
_gp. 482-9
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.2002.tb04306.x
_zAvailable from publisher's website
999 _c11974613
_d11974613